Bornstein Belén, Mas José Antonio, Patrono Clarice, Fernández-Moreno Miguel Angel, González-Vioque Emiliano, Campos Yolanda, Carrozzo Rosalba, Martín Miguel Angel, del Hoyo Pilar, Santorelli Filippo M, Arenas Joaquín, Garesse Rafael
Departamento de Bioquímica, Instituto de Investigaciones Biomédicas Alberto Sols, CSIC-UAM, Facultad de Medicina, Universidad Autónoma de Madrid, 28029 Madrid, Spain.
Biochem J. 2005 May 1;387(Pt 3):773-8. doi: 10.1042/BJ20040949.
Two mutations (G8363A and A8296G) in the mtDNA (mitochondrial DNA) tRNA(Lys) gene have been associated with severe mitochondrial diseases in a number of reports. Their functional significance, however, remains unknown. We have already shown that homoplasmic cybrids harbouring the A8296G mutation display normal oxidative phosphorylation, although the possibility of a subtle change in mitochondrial respiratory capacity remains an open issue. We have now investigated the pathogenic mechanism of another mutation in the tRNA(Lys) gene (G8363A) by repopulating an mtDNA-less human osteosarcoma cell line with mitochondria harbouring either this genetic variant alone or an unusual combination of the two mutations (A8296G+G8363A). Cybrids homoplasmic for the single G8363A or the A8296G+G8363A mutations have defective respiratory-chain enzyme activities and low oxygen consumption, indicating a severe impairment of the oxidative phosphorylation system. Generation of G8363A cybrids within a wild-type or the A8296G mtDNA genetic backgrounds resulted in an important alteration in the conformation of the tRNA(Lys), not affecting tRNA steady-state levels. Moreover, mutant cybrids have an important decrease in the proportion of amino-acylated tRNA(Lys) and, consequently, mitochondrial protein synthesis is greatly decreased. Our results demonstrate that the pathogenicity of the G8363A mutation is due to a change in the conformation of the tRNA that severely impairs aminoacylation in the absence of changes in tRNA stability. The only effect detected in the A8296G mutation is a moderate decrease in the aminoacylation capacity, which does not affect mitochondrial protein biosynthesis.
线粒体DNA(mtDNA)的tRNA(Lys)基因中的两种突变(G8363A和A8296G)在一些报告中与严重的线粒体疾病有关。然而,它们的功能意义仍然未知。我们已经表明,携带A8296G突变的同质性胞质杂种显示出正常的氧化磷酸化,尽管线粒体呼吸能力存在细微变化的可能性仍然是一个悬而未决的问题。我们现在通过用仅携带这种基因变体或两种突变(A8296G + G8363A)的异常组合的线粒体重新填充无mtDNA的人骨肉瘤细胞系,研究了tRNA(Lys)基因中另一种突变(G8363A)的致病机制。单一G8363A或A8296G + G8363A突变的同质性胞质杂种具有缺陷的呼吸链酶活性和低氧消耗,表明氧化磷酸化系统严重受损。在野生型或A8296G mtDNA遗传背景中产生G8363A胞质杂种导致tRNA(Lys)构象发生重要改变,但不影响tRNA的稳态水平。此外,突变胞质杂种中氨基酰化tRNA(Lys)的比例显著降低,因此线粒体蛋白质合成大大减少。我们的结果表明,G8363A突变的致病性是由于tRNA构象的改变,在tRNA稳定性不变的情况下严重损害了氨基酰化。在A8296G突变中检测到的唯一影响是氨基酰化能力适度降低,这并不影响线粒体蛋白质生物合成。